Cinnamate Hybrids: A Unique Family of Compounds with Multiple Biological Activities.
Pontiki E, Peperidou A, Fotopoulos I, Hadjipavlou-Litina D.
Curr Pharm Biotechnol · review; journal article · DOI 10.2174/1389201019666181112102702 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för cinanserin. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
20 träffarEvaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection.
Chiow KH, Phoon MC, Putti T, Tan BK, Chow VT.
Asian Pac J Trop Med · review-article; review; journal article · DOI 10.1016/j.apjtm.2015.12.002Discovery of novel GPVI receptor antagonists by structure-based repurposing.
Taylor L, Vasudevan SR, Jones CI, Gibbins JM, Churchill GC, Campbell RD, Coxon CH.
PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0101209Cinanserin reduces plasma extravasation after burn plasma transfer in rats.
Hernekamp JF, Hu S, Schmidt K, Walther A, Kneser U, Kremer T.
Burns · journal article · DOI 10.1016/j.burns.2013.01.005Activation of the cyclic AMP pathway promotes serotonin-induced Ca2+ oscillations in salivary glands of the blowfly Calliphora vicina.
Fechner L, Baumann O, Walz B.
Cell Calcium · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ceca.2012.10.004Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors.
Yang Q, Chen L, He X, Gao Z, Shen X, Bai D.
Chem Pharm Bull (Tokyo) · journal article · DOI 10.1248/cpb.56.1400Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
Chen L, Gui C, Luo X, Yang Q, Günther S, Scandella E, Drosten C, Bai D, He X, Ludewig B, Chen J, Luo H, Yang Y, Yang Y, Zou J, Thiel V, Chen K, Shen J, Shen X, Jiang H.
J Virol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/jvi.79.11.7095-7103.2005Protective effect of the serotonin receptor antagonist cinanserin in two canine models of pacing-induced myocardial ischemia.
Grover GJ, Parham CS, Youssef S, Ogletree ML.
Pharmacology · journal article · DOI 10.1159/000139294Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity.
Neuman RS, Zebrowska G.
Can J Physiol Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1139/y92-230Tonic immobility and the serotonergic system in chickens: differential blockade of receptors by cyproheptadine and cinanserin.
Hennig CW, Steinhoff WC, Braughler SA.
Physiol Behav · journal article · DOI 10.1016/0031-9384(88)90340-xMorphine and ethanol as discriminative stimuli: absence of antagonism by p-chlorophenylalanine methyl ester, cinanserin, or BC-105.
Winter JC.
Psychopharmacology (Berl) · research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1007/bf00426486Effect of cinanserin, a serotonin antagonist on ethanol preference in the rat.
Geller I, Hartmann RJ, Messiha FS.
Proc West Pharmacol Soc · research support, u.s. gov't, p.h.s.; journal articleEffect of analogs of cinanserin on human lymphocytes in vitro.
Wojnar RJ, Myers DV, Millonig RC, Rahman S, Spahn MA, Hess SM.
Agents Actions · journal article · DOI 10.1007/bf01968542The effects of cinanserin, a potent serotonin antagonist, on the acquisition of a running response in the rat.
Rosen AJ, Cohen ME.
Neuropharmacology · journal article · DOI 10.1016/0028-3908(73)90001-4The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE).
Babington RG, Wedeking PW.
J Pharmacol Exp Ther · journal article · DOI 10.1016/s0022-3565(25)28899-1A clinical trial of an antiserotonin compound, cinanserin, in chronic schizophrenia.
Holden JM, Keskiner A, Gannon P.
J Clin Pharmacol New Drugs · controlled clinical trial; clinical trial; journal article · DOI 10.1177/009127007101100310Clinical and electroencephalographic effects of cinanserin in schizophrenic and manic patients.
Itil TM, Polvan N, Holden JM.
Dis Nerv Syst · controlled clinical trial; clinical trial; journal articleThe effect of cinanserin (antiserotonin agent) on canine renal allografts.
Murphy GP, Brede HD, Weber HW, Groenewald JH, Mirand EA.
J Surg Oncol · journal article · DOI 10.1002/jso.2930020209Treatment of mania with cinanserin, an antiserotonin agent.
Kane FJ.
Am J Psychiatry · journal article · DOI 10.1176/ajp.126.7.1020Pharmacological studies of cinanserin in human isolated smooth muscle.
Metcalfe HL, Turner P.
Br J Pharmacol · research-article; journal article